1. Home
  2. CMPS vs CAN Comparison

CMPS vs CAN Comparison

Compare CMPS & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPS
  • CAN
  • Stock Information
  • Founded
  • CMPS 2020
  • CAN 2013
  • Country
  • CMPS United Kingdom
  • CAN Singapore
  • Employees
  • CMPS N/A
  • CAN N/A
  • Industry
  • CMPS Biotechnology: Pharmaceutical Preparations
  • CAN Semiconductors
  • Sector
  • CMPS Health Care
  • CAN Technology
  • Exchange
  • CMPS Nasdaq
  • CAN Nasdaq
  • Market Cap
  • CMPS 322.5M
  • CAN 384.3M
  • IPO Year
  • CMPS 2020
  • CAN 2019
  • Fundamental
  • Price
  • CMPS $2.79
  • CAN $0.87
  • Analyst Decision
  • CMPS Strong Buy
  • CAN Strong Buy
  • Analyst Count
  • CMPS 7
  • CAN 4
  • Target Price
  • CMPS $21.83
  • CAN $3.88
  • AVG Volume (30 Days)
  • CMPS 1.0M
  • CAN 15.9M
  • Earning Date
  • CMPS 05-07-2025
  • CAN 03-26-2025
  • Dividend Yield
  • CMPS N/A
  • CAN N/A
  • EPS Growth
  • CMPS N/A
  • CAN N/A
  • EPS
  • CMPS N/A
  • CAN N/A
  • Revenue
  • CMPS N/A
  • CAN $269,324,000.00
  • Revenue This Year
  • CMPS N/A
  • CAN $101.48
  • Revenue Next Year
  • CMPS N/A
  • CAN $44.75
  • P/E Ratio
  • CMPS N/A
  • CAN N/A
  • Revenue Growth
  • CMPS N/A
  • CAN 27.35
  • 52 Week Low
  • CMPS $2.69
  • CAN $0.72
  • 52 Week High
  • CMPS $10.31
  • CAN $3.27
  • Technical
  • Relative Strength Index (RSI)
  • CMPS 31.50
  • CAN 30.30
  • Support Level
  • CMPS $2.88
  • CAN $0.94
  • Resistance Level
  • CMPS $3.16
  • CAN $1.10
  • Average True Range (ATR)
  • CMPS 0.21
  • CAN 0.08
  • MACD
  • CMPS -0.03
  • CAN 0.01
  • Stochastic Oscillator
  • CMPS 9.30
  • CAN 22.71

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About CAN Canaan Inc.

Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment as well as the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts.

Share on Social Networks: